Three-dimensional cultures (or “organoids”) derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study published May 7 in Cell. These “organoid” cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.
“This is the first time that a collection of cancer organoids, or a living biobank, has been derived from patient tumors,” says senior study author Mathew Garnett, a geneticist at the Wellcome Trust Sanger Institute. “We believe that these organoids are an important new tool in the arsenal of cancer biologists and may ultimately improve our ability to develop more effective cancer treatments.”
To study the causes of cancer and develop new cancer treatments, many laboratories use experimental model systems such as cells grown from patient tumors. However, currently available cell lines have been derived under suboptimal conditions and therefore fail to reflect important features of tumor cells. As a result, it has been challenging to predict the drug sensitivity of individual patients based on their unique spectrum of genetic mutations.
In recent years, scientists have developed organoid cell culture systems as an alternative approach to grow normal and diseased tissue in a dish. In contrast to cell lines, organoids display the hallmarks of the original tissue in terms of its 3D architecture, the cell types present, and their self-renewal properties. Given the advantages of organoids, Garnett and Hans Clevers of the Hubrecht Institute set out to test whether these cultures could potentially bridge the gap between cancer genetics and patient outcomes.
In the new study, the researchers grew 22 organoids derived from tumor tissue from 20 patients with colorectal cancer and then sequenced genomic DNA isolated from these cultures. The genetic mutations in the organoid cultures closely matched those in the corresponding tumor biopsies and agreed well with previous large-scale analyses of colorectal cancer mutations. These findings confirm that the cultures faithfully capture the genomic features of the tumors from which they are derived as well as much of the genomic diversity associated with colorectal cancer.
To link drug sensitivity to genetic changes, the researchers next screened the responses of the organoids to 83 experimental and approved cancer drugs. Given their diverse genetic profiles, the organoids displayed a range of sensitivities to the drugs. In validation of the approach, the researchers identified previously reported associations between specific mutations and resistance to particular drugs. The organoids also revealed a novel gene-drug association, indicating that the subset of cancer patients with RNF43 mutations would strongly benefit from a drug that inhibits a protein called porcupine. “At some point in the future, this approach may be suitable for modeling individual patient response to cancer therapies to inform clinical treatment,” Garnett says.
The Latest on: Organoids
via Google News
The Latest on: Organoids
- Using organoids to improve chemotherapy for advanced stages of colon and appendiceal canceron August 7, 2020 at 7:48 am
New research published in the journal Annals of Surgical Oncology uses organoids to finetune chemotherapies that treat patients with advanced stages of colon and appendiceal cancer. Organoids are 3D ...
- PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial–mesenchymal transitionon August 7, 2020 at 4:04 am
The SUMO E3 ligases PIAS1 and TIF1γ target the transcriptional regulator SnoN for SUMOylation leading to suppression of epithelial–mesenchymal transition (EMT). Whether and how TIF1γ and PIAS1 might ...
- Chemotherapy for rare cancer fine-tuned with organoidson August 6, 2020 at 10:13 pm
A patient-specific tumor organoid model is being used to identify the most effective chemotherapy protocol to treat appendix and colon tumors, a personalized medicine approach that is showing promise.
- Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoidson August 6, 2020 at 5:11 pm
Despite extensive genetic and neuroimaging studies, detailed cellular mechanisms underlying schizophrenia and bipolar disorder remain poorly understood. Recent progress in single-cell RNA sequencing ...
- Organoids help bridge gap between laboratory study and animal modeling of colorectal canceron August 5, 2020 at 1:12 pm
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have biofabricated human colorectal cancer miniature organs, called organoids, to better understand how a tumor grows in its ...
- Organoids help bridge gap between laboratory study and animal modeling of diseaseon August 5, 2020 at 12:39 pm
A new study from the Wake Forest Institute for Regenerative Medicine is the first to replicate observations of native tumor tissue in a laboratory model and validate it in the context of the ...
- Researchers Growing Mini-Lungs To Study Coronavirus Impacts On Different Race, Genderon August 4, 2020 at 6:39 am
San Diego scientists are growing mini-lungs from a diverse set of stem cells to see how COVID-19 impacts the organ. Researchers are hoping the study shows how coronavirus affects people from different ...
- Singapore scientists take major step in finding new therapies for non-alcoholic fatty liver diseaseon July 31, 2020 at 12:06 pm
SINGAPORE: Singapore scientists have taken a major step towards devising better therapies for liver diseases after creating human liver organoids that are able to replicate structural changes ...
- Scientists develop human lung organoids to study SARS-CoV-2 infectionon July 29, 2020 at 11:10 pm
Now, a new study published on the preprint server bioRxiv in July 2020 reports the development of a human distal lung culture system that can be functionally tested. This will help not only to ...
- Inflammation induced blood-brain barrier dysfunction studied in organoidson July 29, 2020 at 5:00 pm
They reported that the organoids promoted the formation of a fully cell-based, natural and functional barrier -- the blood brain barrier -- that mimics normal human anatomy. The blood brain ...
via Bing News